Literature DB >> 5043377

Clinical pharmacology of cephalexin administered by intravenous injection.

J A Davies, J M Holt.   

Abstract

Cephalexin IG was given by intravenous injection to eight normal volunteers, five patients with chronic renal failure, and three patients during a period of haemodialysis. In normal subjects there was a rapid fall in serum concentration and 80% of the administered dose was excreted in the urine within two hours. The mean serum half life was 1.1 hours (range 0.6-1.8 hours). Prior treatment with probenecid in two subjects led to a twofold increase in serum concentration two hours after injection. In the patients with chronic renal failure antimicrobial activity persisted for 24 hours and the half life ranged from 6.1 to 18.1 hours. Haemodialysis led to partial removal of cephalexin from the blood, but antimicrobial activity remained eight hours after injection at the end of the dialysis period. The serum half life in these patients was 5.1, 5.6, and 5.7 hours.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5043377      PMCID: PMC477369          DOI: 10.1136/jcp.25.6.518

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity.

Authors:  C M KUNIN; M FINLAND
Journal:  N Engl J Med       Date:  1958-11-20       Impact factor: 91.245

2.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

3.  Oral cephalexin and ampicillin: antimicrobial activity, recovery in urine, and persistence in blood of uremic patients.

Authors:  C M Kunin; Z Finkelberg
Journal:  Ann Intern Med       Date:  1970-03       Impact factor: 25.391

4.  Cephalexin therapy as related to renal function.

Authors:  S A Kabins; B Kelner; E Walton; E Goldstein
Journal:  Am J Med Sci       Date:  1970-02       Impact factor: 2.378

5.  Clinical pharmacology of cephalexin administered intravenously.

Authors:  J B De Maine; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  Cephalexin: human studies of absorption and excretion of a new cephalosporin antibiotic.

Authors:  P E Gower; C H Dash
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

7.  Cephalexin, a new orally absorbed cephalosporin antibiotic.

Authors:  W E Wick
Journal:  Appl Microbiol       Date:  1967-07
  7 in total
  3 in total

1.  Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.

Authors:  C Regamey; R D Libke; J T Clarke; W M Kirby
Journal:  Infection       Date:  1974       Impact factor: 3.553

2.  Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

Review 3.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.